Dermatofibrosarcoma: Clinical Trials

2 trials for Dermatofibrosarcoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 32Completed 2
Phase 21Completed 1

Follow Dermatofibrosarcoma: new trials by email Literature Review of Dermatofibrosarcoma trials Research Report on Dermatofibrosarcoma

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Before Surgery in Treating Patients With Newly Diagnosed Non-rhabdomyosarcoma Soft Tissue Sarcomas That Can Be Removed by Surgery
Doxorubicin, Doxorubicin Hydrochloride, Ifosfamide - Alveolar Soft Part Sarcoma, Angiomatoid Fibrous Histiocytoma
Phase 2 / Phase 3CompletedNational Cancer Institute (NCI)1402014-08-122026-06-17
Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma
doxorubicin hydrochloride, clinical observation, therapeutic conventional surgery - Adult Alveolar Soft-part Sarcoma, Adult Angiosarcoma
Phase 3CompletedChildren's Oncology Group5882007-02-052022-04-28

Narrower conditions

Chondrosarcoma, Extraskeletal Myxoid (2)  ·  Fibrosarcoma (2)  ·  Histiocytoma, Malignant Fibrous (2)  ·  Leiomyosarcoma (2)  ·  Liposarcoma (2)  ·  Neurofibrosarcoma (2)  ·  Sarcoma (2)  ·  Sarcoma, Alveolar Soft Part (2)  ·  Sarcoma, Synovial (2)  ·  Chondrosarcoma, Mesenchymal (1)  ·  Granuloma, Plasma Cell (1)  ·  Hemangiopericytoma, Malignant (1)  ·  Hemangiosarcoma (1)  ·  Histiocytoma, Angiomatoid Fibrous (1)

Broader conditions

Histiocytoma (2)  ·  Neoplasms (2)  ·  Neoplasms by Histologic Type (2)  ·  Neoplasms, Adipose Tissue (2)  ·  Neoplasms, Connective Tissue (2)  ·  Neoplasms, Connective and Soft Tissue (2)  ·  Neoplasms, Fibrous Tissue (2)  ·  Neoplasms, Muscle Tissue (2)  ·  Neoplasms, Nerve Tissue (2)  ·  Nervous System Diseases (2)  ·  Nervous System Neoplasms (2)  ·  Neurofibroma (2)  ·  Neuromuscular Diseases (2)  ·  Peripheral Nervous System Diseases (2)  ·  Peripheral Nervous System Neoplasms (2)

Interventions

Doxorubicin (2)  ·  Ifosfamide (2)  ·  Observation (1)  ·  Radiation (1)  ·  Radiotherapy (1)  ·  Radiotherapy, Conformal (1)  ·  Watchful Waiting (1)  ·  indolepropanol phosphate (1)  ·  pazopanib (1)

Sponsors

Children's Oncology Group (1)  ·  National Cancer Institute (NCI) (1)

Countries

Canada (2)  ·  Puerto Rico (2)  ·  United States (2)  ·  Australia (1)  ·  New Zealand (1)

Top investigators

Aaron R Weiss (1)  ·  Sheri Spunt, MD (1)

Results publications

PMID 28391003, PMID 30954717, PMID 31786124, PMID 32702309, PMID 32827353, PMID 33548339, PMID 34515544, PMID 34623899, PMID 36566574, PMID 37523624, PMID 38757485, PMID 41386267

NIH funding

U10CA098543 (2), U10CA180830 (1), U10CA180886 (1)